JDD in the Media

Could You Be Allergic to Additives?

By December 30, 2019February 14th, 2020No Comments
A recent article from US News, “Could You Be Allergic to Additives?” cites a January 2013  JDD study  on whether common additives in food or medications can cause reactions in some people.
The study, “Medication Dyes as a Source of Drug Allergy,” states “Excipients are defined as inert substances added to a drug or food to confer a suitable consistency, appearance, or form. They may be added for bulk, to change dissolution or the kinetics of absorption, to improve stability, to influence palatability, or to create a distinctive appearance. The last function may depend heavily on the use of coloring agents, especially when there are multiple dosages (such as with warfarin), and dose confusion may result in profound complications. While described as inert, excipients have been associated with triggering immunological reactions, although this is almost never considered in common practice when patients have reactions to medications, even when they appear to react to many different and distinct drugs.”
Read Article Now

You May Also Like

Atopic DermatitisFeatured ArticlesJDD HighlightsJDD in the MediaThe Latest
September 22, 2025

JDD in the News: Pharmacy Deserts and Affordability Concerns in Atopic Dermatitis Care

Healio profiled a July Journal of Drugs in Dermatology study on the affordability of dermatologist-recommended skincare products for atopic dermatitis. The study, “Socioeconomic Disparities in Gentle Skin Care Access for…
Featured ArticlesJDD HighlightsJDD in the MediaSkincareThe Latest
August 18, 2025

JDD in the News: Perceived Dermatologic Side Effects of Cancer Treatments

Several media outlets covered an August Journal of Drugs in Dermatology survey on the perceived dermatologic side effects of cancer treatments and how those perceptions could impact a person’s decision…
JDD HighlightsJDD in the MediaSkin CancerThe Latest
June 23, 2025

Dermatology Roundup: Drug Class Effective Against Treatment-Resistant Melanoma

Researchers at NYU Langone Health and the Perlmutter Cancer Center have discovered why many patients with melanoma are resistant to current treatments and how an existing drug class is effective…

Leave a Reply